Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析

◆英語タイトル:Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15900
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,625見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Kowa Co Ltd (7807) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kowa Co Ltd (Kowa) manufactures over the counter (OTC) products, ethical drugs and medical equipment; imports and exports LED lighting equipment, optical equipment and renewable energy power generation systems; and trading of textile, life style products, construction materials, machinery, chemicals and commodities. The company also trades various items, such as pharmaceutical ingredients, ingredients for cosmetics, monomers and specialty chemicals, oil and fats, feed additives, activated carbon and coal, industrial machinery and equipment and vessels. The company operates through its subsidiaries and affiliates across Japan, North America, Latin America, Europe, Asia and Oceania. Kowa is headquartered in Nagoya, Aichi, Japan.

Kowa Co Ltd Key Recent Developments

Apr 30,2018 SQM Announces End of Controller Group Agreement

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Kowa Co Ltd – Key Facts
Kowa Co Ltd – Key Employees
Kowa Co Ltd – Key Employee Biographies
Kowa Co Ltd – Major Products and Services
Kowa Co Ltd – History
Kowa Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Kowa Co Ltd – Business Description
Kowa Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Kowa Co Ltd – Strengths
Kowa Co Ltd – Weaknesses
Kowa Co Ltd – Opportunities
Kowa Co Ltd – Threats
Kowa Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Kowa Co Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 30, 2018: SQM Announces End of Controller Group Agreement
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Kowa Co Ltd, Key Facts
Kowa Co Ltd, Key Employees
Kowa Co Ltd, Key Employee Biographies
Kowa Co Ltd, Major Products and Services
Kowa Co Ltd, History
Kowa Co Ltd, Other Locations
Kowa Co Ltd, Subsidiaries
Kowa Co Ltd, Joint Venture
Kowa Co Ltd, Key Competitors
Kowa Co Ltd, Ratios based on current share price
Kowa Co Ltd, Annual Ratios
Kowa Co Ltd, Annual Ratios (Cont...1)
Kowa Co Ltd, Annual Ratios (Cont...2)
Kowa Co Ltd, Interim Ratios
Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Kowa Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Kowa Co Ltd, Performance Chart (2016 - 2018)
Kowa Co Ltd, Ratio Charts
Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Kowa Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Children’s Hospital of Philadelphia:企業のM&A・提携動向(医療分野)
    Summary The Children's Hospital of Philadelphia (CHOP) is a childcare specialty hospital that provides pediatric healthcare solutions. The hospital offers treatments for pediatric healthcare, and promotes children’s health through its medical discoveries. It carries out research in the areas of card …
  • Manulife Financial Corporation:企業のM&A・事業提携・投資動向
    Manulife Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Manulife Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Golden Agri-Resources Ltd:企業の戦略・SWOT・財務情報
    Golden Agri-Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Golden Agri-Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Britvic plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Britvic plc Mergers and Acquisi …
  • Aluminium Company of Malaysia Berhad:企業の戦略・SWOT・財務分析
    SummaryAluminium Company of Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Quintiles Transnational Holdings Inc.:企業の戦略・SWOT・財務分析
    SummaryQuintiles Transnational Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of th …
  • Debenhams plc:企業の戦略・SWOT・財務分析
    Debenhams plc - Strategy, SWOT and Corporate Finance Report Summary Debenhams plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Toronto-Dominion Bank:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The Toronto-Dominion Bank" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • HAI Argochem Joint Stock Company (HAI):企業財務及び戦略的SWOT分析
    Summary HAI Argochem Joint Stock Company (HAI JSC) is a chemical company that manufactures and trades agrochemical products. The company’s products include insecticides, fungicides, herbicides, plant growth regulators and fertilizers. It also sells corn seeds, plastic resin pellets and other farm su …
  • Oxtex Limited:企業のM&A・提携動向(医療機器分野)
    Summary Oxtex Limited (Oxtex), formerly oxtexs limited is a medical device company that develops wide range of novel devices for the expansion of soft tissue. The company’s product includes implantable self-inflating tissue expanders in different sizes and shapes that are suitable for specific needs …
  • FP Corporation:企業の戦略・SWOT・財務情報
    FP Corporation - Strategy, SWOT and Corporate Finance Report Summary FP Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • 2020 GeneSystems Inc:企業のM&A・提携動向(医療分野)
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company that develops and commercializes diagnostic tests and proteomics products for early disease detection, therapy selection and biodefense applications. It offers tests in the areas such as personalized medicine, early detection …
  • Singapore Airport Terminal Services, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Singapore Airport Terminal Serv …
  • Neways Electronics International N.V. (NEWAY):企業概要、財務及び戦略的SWOT分析
    Summary Neways Electronics International N.V. (Neways) is an electronic component provider. The company provides assemblies and systems. It also offers solution for the development, engineering, testing and manufacture of small to medium-sized batches of electrical circuits and printed circuit board …
  • Singapore Post Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Singapore Post Limited Mergers …
  • MediGene AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' MediGene AG Mergers and Acquisi …
  • Tabuk Pharmaceuticals Manufacturing Company:企業のM&A・提携動向(医療分野)
    Summary Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group is a pharmaceutical company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products . The company offers products in various therapeutic areas including ali …
  • Natcore Technology, Inc. (NXT):企業概要、財務及び戦略的SWOT分析
    Summary Natcore Technology, Inc. (Natcore) is a thin film technology company. The company offers products for semiconductor and fiber optic applications. Its products include silicon dioxide and black silicon. Natcore’s liquid phase deposition technology offers controlled deposition of silicon dioxi …
  • Allergan Plc (AGN):企業の財務・戦略的SWOT分析
    Allergan Plc (AGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Repligen Corporation (RGEN):企業概要、財務及び戦略的SWOT分析
    Summary Repligen Corporation (Repligen) is a life sciences company. It undertakes the development and commercialization of high value consumable products, which are used in the process of manufacturing biological drugs. The company’s product portfolio includes rProtein A affinity resins, protein A E …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆